Fraction Conversion Models Based on Ultrasound Attenuation Coefficient for Assessing Liver Steatosis
Diagnostics · 03.04.2026 · 16 (7) · 1086
DOI: 10.3390/diagnostics16071086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 03.04.2026. Verfasst von Yin Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Ultrasound, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Guangzhou Science and Technology Plan Project.
Abstract (Originalsprache)
Objectives
We aimed to develop models capable of converting the attenuation coefficient (AC) into a percentage-like index in patients with suspected metabolic dysfunction-associated steatotic liver disease (MASLD).
Methods
In this retrospective, cross-sectional study, we consecutively enrolled participants with suspected MASLD from the Weight Loss Medical Centre who had undergone both ultrasound examinations that yielded AC results and magnetic resonance imaging (MRI) scans including proton density fat fraction (PDFF). The first model, defined as the PDFF conversion fraction (PCF), used the MRI-PDFF results as the reference standard. The other model, defined as the attenuation level fraction (ALF), converted AC values into percentages based on the range of AC values from 0.5 to 1.0 dB/cm/MHz. Area under the receiver operating characteristic curve (AUC) analysis was used to evaluate the diagnostic performance of the two models.
Results
Among the 199 participants (mean age, 38.12 ± 9.56 years; 110 male), the PDFF values differed significantly among the different liver segments (p < 0.05). The PDFF values of the left liver and right liver were 12.6% and 16.1%, respectively. There was a significant difference between them (p < 0.05). The AUCs of the AC, PCF, and ALF were 0.92, 0.93, and 0.87, respectively, for detecting mild steatosis (≥ S1), moderate steatosis (≥S2), and severe steatosis (≥S3) when PDFF values ≥ 5%, ≥15%, and ≥25% were used as the reference standard, respectively.
Conclusions
The two fraction conversion models (PCF and ALF) yielded good and identical diagnostic accuracies in grading liver steatosis. Considering the heterogeneous pattern of liver steatosis, the ALF was a more objective parameter.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Ultrasound, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China.
- Department of Radiology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China.
- Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China.
- Department of Medical Ultrasound, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou Municipal Key Laboratory of Mechanistic and Translational Obesity Research, The Third Affiliated Hospital of Sun Yat-Sen Un…
ORCID-Profile: Jie Zeng
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangzhou Science and Technology Plan Project
Zitieren
APA
Zhang, Y., Jiang, T., Xu, C., He, J., Zhang, H., Chen, T., & Zeng, J. (2026). Fraction Conversion Models Based on Ultrasound Attenuation Coefficient for Assessing Liver Steatosis. Diagnostics, 16(7), 1086. https://doi.org/10.3390/diagnostics16071086
Vancouver
Zhang Y, Jiang T, Xu C, He J, Zhang H, Chen T, et al. Fraction Conversion Models Based on Ultrasound Attenuation Coefficient for Assessing Liver Steatosis. Diagnostics. 2026;16(7):1086. doi:10.3390/diagnostics16071086
BibTeX
@article{Zhang2026,
author = {Zhang, Yin and Jiang, Ting and Xu, Chuli and He, Jiajun and Zhang, Hongjun and Chen, Tufeng and Zeng, Jie},
title = {Fraction Conversion Models Based on Ultrasound Attenuation Coefficient for Assessing Liver Steatosis},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {7},
pages = {1086},
doi = {10.3390/diagnostics16071086}
}
EUVIMED